CURE will host a webinar, sponsored by Amgen, in which panelists from several cancer organizations will discuss ways to improve awareness around biomarker testing, improve coordination of care for patients with lung cancer and remove barriers to access to care.
CURE® is proud present the EDUCATED PATIENT® Gastrointestinal Stromal Tumor (GIST) Webinar from Tuesday, January 26, 2021.
A roundup of some skin cancer news and updates that occurred in 2020 that patients may have missed.
A roundup of some kidney cancer news and updates that occurred in 2020 that patients may have missed.
A roundup of some ovarian cancer news and updates that occurred in 2020 that patients may have missed.
Here are the top 10 most popular contributor articles from 2020!
A roundup of some of the most read news and updates in breast cancer in 2020 from CURE®.
A roundup of some of the most read news and updates in follicular lymphoma in 2020 from CURE ®.
A roundup of some of the most read news and updates in mantle cell lymphoma in 2020 from CURE®.
A roundup of some of the most read news and updates in acute myeloid leukemia in 2020 from CURE®.
The approval of an investigational new drug application will allow Berubicin’s manufacturer to begin studying the investigational drug in adults with glioblastoma who have previously failed their first treatment.
The decision was based on data that demonstrated sotorasib induced anticancer activity and achieved a positive benefit-risk profile in patients with locally advanced or metastatic non-small cell lung cancer whose disease harbors a KRAS G12C mutation.
View the full CURE® Educated Patient® Summit on Prostate Cancer here!
Santure was recognized for her compassionate care for patients and their families; also during virtual ceremony, Elizabeth Farrat named 2020 The Finest Hour award winner.
Charles J. Ryan, M.D., internationally recognized for his research on prostate cancer, discusses risk factors, treatments and racial disparities associated with the disease.
A roundup of the latest news and updates for patients with metastatic breast cancer from CURE®.
A roundup of the latest news and updates for patients with prostate cancer from CURE®.
Join us for our Chronic Lymphocytic Leukemia webinar where experts discuss CLL information highly relevant to patients, caregivers, advocates and discuss patient questions.
On social media, CURE® recently asked its readers to share some tips for others for coping with roadblocks they might experience on their cancer journey. Here, we share some of their responses.
On social media, CURE® recently asked its readers to share how they pamper and treat themselves during or after their cancer treatment. Here, we share some of their responses.
On social media, CURE® recently asked its readers to share how they cope with anxiety leading up to their next scans. Here, we share some of their responses.
The FDA’s fast track designation for BST-236 to treat adults aged 75 years or older with acute myeloid leukemia, or who have comorbidities that prevent the use of intensive induction chemotherapy, may open the doors to an accelerated approval.
On social media, CURE® recently asked its readers to share the advice they would give someone looking to help a friend or loved one with cancer. Here, we share some of their responses.
A roundup of the latest news and updates for patients with ovarian cancer from CURE®.
The Food and Drug Administration has had a busy summer, approving new agents to treat a variety of cancers. Here are five recent approvals that patients with cancer may have missed.
Leading experts in the CLL landscape discuss the latest treatment options for patients and answer questions from the CURE audience.
We asked and you answered! Here's what CURE readers had to say about whether or not their care teams helped with crafting a survivorship plan.
Here is a list of the recent trial initiations that occurred within the cancer space in June.
In partnership with CURE®, Susan G. Komen Greater New York City hosts its 4th Annual Patient Navigation Town Hall "Empowering and Mobilizing Our Patient Navigation Workforce". Oncologists, community health workers and patient navigators will get together on June 23rd, via webinar, to discuss the impact of the COVID-19 pandemic on the cancer landscape and how professionals and patients can navigate the fallout moving forward.
4 Chronic Lymphocytic Leukemia experts hosted a webinar, in partnership with CURE, addressing the latest and most important topics for patients with CLL.
